CUSIP: 66987V109
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Total 13F shares
-
255,853,374
-
Share change
-
+4,145,749
-
Total reported value
-
$20,683,549,265
-
Put/Call ratio
-
55%
-
Price per share
-
$80.85
-
Number of holders
-
1,006
-
Value change
-
+$332,779,564
-
Number of buys
-
434
-
Number of sells
-
435
Quarterly Holders Quick Answers
What is CUSIP 66987V109?
CUSIP 66987V109 identifies NVS - NOVARTIS AG - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 66987V109:
Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q1 2018
As of 31 Mar 2018,
NOVARTIS AG - Ordinary Shares (NVS) was held by
1,006 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
255,853,374 shares.
The largest 10 holders included
DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, FRANKLIN RESOURCES INC, PARNASSUS INVESTMENTS /CA, BROWN BROTHERS HARRIMAN & CO, WELLS FARGO & COMPANY/MN, LOOMIS SAYLES & CO L P, Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, and UBS Group AG.
This page lists
1,006
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.